Research Reviews
FOXO4-DRI Human Trials: What the Evidence Covers
Searches for FOXO4-DRI human trials return nothing. The evidence is structural and cell-based, and one study found senolysis made things worse.
Ageing biology as it is actually studied: senescence markers, mitochondrial function, telomere work and the bioregulator literature. These articles describe what has been measured in models and are explicit about the distance between a model result and any claim about human ageing.
Research Reviews
Searches for FOXO4-DRI human trials return nothing. The evidence is structural and cell-based, and one study found senolysis made things worse.
Comparisons
NAD+ is a nucleotide coenzyme; MOTS-c a 16-residue peptide encoded in mitochondrial DNA. Both connect to mitochondria, but through quite different routes.
Peptide Profiles
FOXO4-DRI is a retro-inverso peptide designed to disrupt the FOXO4-p53 interaction. What DRI means chemically, and what the 2025 work established.
Research Reviews
Thymalin, Cardiogen, Cortagen and Crystagen come from the Khavinson bioregulator programme. What the class is and how to read its literature.
Peptide Profiles
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial 12S rRNA. Its discovery, AMPK and folate-cycle mechanism, exercise and ageing research, and handling.
Peptide Profiles
NAD+ is a nucleotide coenzyme, not a peptide. Its structure, redox and non-redox roles, the age-related decline literature, and how to handle it in the lab.
Peptide Profiles
Epithalon (Ala-Glu-Asp-Gly) was derived from the pineal extract epithalamin. Its structure, telomerase and lifespan studies, and how to read that literature.
Lab Handling
How to reconstitute NAD+ powder for research: concentration tables for 100-1000 mg vials, molar conversion at 663.4 g/mol, buffer choice and stability.
Comparisons
NAD, NAD+ and NADH are the same coenzyme in different states. What the plus sign means, which form is oxidised, and why the ratio matters in the lab.
Comparisons
NMN is a direct precursor of NAD+, about half its size. How they differ in structure, how NMN becomes NAD+, what the human trial showed, and lab handling.